Miles Gregory Cunningham, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microinjections | 3 | 2019 | 321 | 1.140 |
Why?
|
| Electroconvulsive Therapy | 3 | 2016 | 505 | 0.800 |
Why?
|
| Amygdala | 5 | 2009 | 1380 | 0.670 |
Why?
|
| Stereotaxic Techniques | 3 | 2019 | 553 | 0.620 |
Why?
|
| Infusion Pumps | 2 | 2008 | 163 | 0.550 |
Why?
|
| Prefrontal Cortex | 5 | 2007 | 2238 | 0.520 |
Why?
|
| Neuronavigation | 1 | 2017 | 168 | 0.500 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 4063 | 0.470 |
Why?
|
| Neurology | 3 | 2006 | 786 | 0.420 |
Why?
|
| Brain | 8 | 2019 | 27360 | 0.410 |
Why?
|
| Catheterization | 2 | 2008 | 1430 | 0.400 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2009 | 1141 | 0.390 |
Why?
|
| Models, Neurological | 3 | 2017 | 1776 | 0.380 |
Why?
|
| Stem Cell Transplantation | 3 | 2009 | 1596 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2017 | 8128 | 0.370 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 1107 | 0.370 |
Why?
|
| Suicide | 1 | 2021 | 1606 | 0.330 |
Why?
|
| Blindness, Cortical | 1 | 2009 | 17 | 0.320 |
Why?
|
| Brain Tissue Transplantation | 1 | 2009 | 81 | 0.320 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2009 | 139 | 0.320 |
Why?
|
| Psychiatry | 3 | 2006 | 1716 | 0.310 |
Why?
|
| Dissociative Disorders | 1 | 2010 | 235 | 0.300 |
Why?
|
| Artifacts | 1 | 2017 | 1926 | 0.300 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 851 | 0.300 |
Why?
|
| Dementia, Vascular | 1 | 2009 | 125 | 0.290 |
Why?
|
| Biogenic Monoamines | 1 | 2007 | 50 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2232 | 0.290 |
Why?
|
| Central Nervous System Agents | 1 | 2008 | 73 | 0.290 |
Why?
|
| Microtomy | 1 | 2007 | 44 | 0.290 |
Why?
|
| Efferent Pathways | 1 | 2007 | 165 | 0.280 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2007 | 158 | 0.270 |
Why?
|
| Electrophysiology | 2 | 2009 | 1266 | 0.270 |
Why?
|
| Rats | 12 | 2017 | 23760 | 0.270 |
Why?
|
| Interneurons | 2 | 2008 | 591 | 0.260 |
Why?
|
| Neuropsychology | 1 | 2006 | 110 | 0.250 |
Why?
|
| Raphe Nuclei | 1 | 2005 | 104 | 0.240 |
Why?
|
| Neurons | 4 | 2009 | 9514 | 0.240 |
Why?
|
| Nervous System Diseases | 2 | 2006 | 1662 | 0.230 |
Why?
|
| Serotonin | 2 | 2007 | 1043 | 0.230 |
Why?
|
| Cerebral Infarction | 1 | 2009 | 969 | 0.220 |
Why?
|
| Zinc | 1 | 2007 | 677 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2005 | 291 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2016 | 2893 | 0.200 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 564 | 0.200 |
Why?
|
| Neural Pathways | 5 | 2017 | 3117 | 0.200 |
Why?
|
| Dopamine | 2 | 2007 | 1592 | 0.190 |
Why?
|
| Basal Ganglia | 1 | 2004 | 553 | 0.190 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1250 | 0.180 |
Why?
|
| Interdisciplinary Communication | 1 | 2006 | 937 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2007 | 1485 | 0.170 |
Why?
|
| Mental Disorders | 4 | 2012 | 6874 | 0.160 |
Why?
|
| Injections, Intraventricular | 1 | 2019 | 227 | 0.160 |
Why?
|
| Lysine | 1 | 2002 | 1000 | 0.150 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2017 | 20 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2748 | 0.150 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 54 | 0.140 |
Why?
|
| Electroencephalography | 4 | 2007 | 6314 | 0.140 |
Why?
|
| Anatomy, Artistic | 1 | 2017 | 51 | 0.140 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 133 | 0.140 |
Why?
|
| Depression | 1 | 2016 | 8230 | 0.140 |
Why?
|
| Glutamate Decarboxylase | 1 | 2017 | 239 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 11095 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 248 | 0.130 |
Why?
|
| Nerve Net | 1 | 2007 | 2352 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2007 | 3721 | 0.120 |
Why?
|
| Subtraction Technique | 1 | 2017 | 517 | 0.110 |
Why?
|
| Animals | 15 | 2017 | 169246 | 0.110 |
Why?
|
| Cognition | 2 | 2009 | 7073 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2017 | 680 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1191 | 0.100 |
Why?
|
| Species Specificity | 1 | 2017 | 2415 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 2016 | 493 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 1462 | 0.090 |
Why?
|
| Religion and Psychology | 1 | 2012 | 180 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2005 | 2678 | 0.080 |
Why?
|
| Equipment Design | 2 | 2009 | 3522 | 0.080 |
Why?
|
| Gyrus Cinguli | 2 | 2007 | 1135 | 0.080 |
Why?
|
| Aging | 1 | 2007 | 8744 | 0.080 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2007 | 27 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 272 | 0.070 |
Why?
|
| Rosaniline Dyes | 1 | 2007 | 50 | 0.070 |
Why?
|
| Sodium Selenite | 1 | 2007 | 11 | 0.070 |
Why?
|
| Swine, Miniature | 1 | 2009 | 965 | 0.070 |
Why?
|
| Stilbamidines | 1 | 2007 | 43 | 0.070 |
Why?
|
| Maze Learning | 1 | 2009 | 482 | 0.070 |
Why?
|
| Rats, Inbred WKY | 1 | 2007 | 150 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2909 | 0.070 |
Why?
|
| Electrophysiological Phenomena | 1 | 2008 | 309 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 367 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6029 | 0.070 |
Why?
|
| Sympatholytics | 1 | 2005 | 82 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 563 | 0.060 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2007 | 417 | 0.060 |
Why?
|
| Oxidopamine | 1 | 2005 | 169 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 580 | 0.060 |
Why?
|
| Review Literature as Topic | 1 | 2007 | 297 | 0.060 |
Why?
|
| Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
| Blindness | 1 | 2009 | 587 | 0.060 |
Why?
|
| Citalopram | 1 | 2007 | 401 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 7140 | 0.060 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2007 | 491 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2009 | 587 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 13014 | 0.060 |
Why?
|
| Denervation | 1 | 2005 | 265 | 0.060 |
Why?
|
| Male | 13 | 2017 | 364719 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3833 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20227 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2017 | 6283 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2010 | 1200 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2004 | 305 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5804 | 0.050 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2004 | 246 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2009 | 1003 | 0.050 |
Why?
|
| Action Potentials | 2 | 2008 | 1838 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2007 | 733 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14729 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1862 | 0.050 |
Why?
|
| Neurosciences | 1 | 2006 | 383 | 0.050 |
Why?
|
| Female | 7 | 2021 | 397192 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2007 | 1191 | 0.050 |
Why?
|
| Microspheres | 1 | 2004 | 788 | 0.050 |
Why?
|
| Humans | 11 | 2021 | 768166 | 0.040 |
Why?
|
| Visual Perception | 1 | 2009 | 1402 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2005 | 1741 | 0.040 |
Why?
|
| Fear | 1 | 2009 | 1495 | 0.040 |
Why?
|
| Somatosensory Cortex | 1 | 2004 | 516 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2004 | 1888 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1667 | 0.040 |
Why?
|
| Swine | 1 | 2009 | 5995 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2560 | 0.040 |
Why?
|
| Motor Activity | 1 | 2009 | 2711 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1930 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 1514 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2007 | 11669 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2007 | 4146 | 0.040 |
Why?
|
| Cell Communication | 1 | 2005 | 1660 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2008 | 18349 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2937 | 0.040 |
Why?
|
| Synapses | 1 | 2007 | 1765 | 0.040 |
Why?
|
| Age Factors | 2 | 2005 | 18412 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 2017 | 229 | 0.030 |
Why?
|
| Middle Aged | 4 | 2016 | 223492 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65371 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3785 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6793 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2006 | 2523 | 0.030 |
Why?
|
| Graft Survival | 1 | 2004 | 3887 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2010 | 5130 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2006 | 3620 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 762 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2007 | 4530 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19015 | 0.020 |
Why?
|
| Emotions | 1 | 2002 | 2767 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 36743 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6983 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2008 | 61 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2008 | 59 | 0.020 |
Why?
|
| GABA Antagonists | 1 | 2008 | 119 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 367 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 9118 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 40218 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2008 | 1090 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 15597 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 59629 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2017 | 12800 | 0.010 |
Why?
|
| Stroke | 1 | 2004 | 9755 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 82029 | 0.010 |
Why?
|
| United States | 1 | 2006 | 73039 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 223646 | 0.010 |
Why?
|